BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3
32 results:

  • 1. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
    Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
    J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cytotoxic lymphocytes-related gene ITK from a systematic CRISPR screen could predict prognosis of ovarian cancer patients with distant metastasis.
    Xu M; Huang S; Chen J; Xu W; Xiang R; Piao Y; Zhao S
    J Transl Med; 2021 Oct; 19(1):447. PubMed ID: 34702300
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. IFN-γ inhibits ovarian cancer progression via socs1/JAK/STAT signaling pathway.
    Gao AH; Hu YR; Zhu WP
    Clin Transl Oncol; 2022 Jan; 24(1):57-65. PubMed ID: 34275119
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Color-Coded Imaging of cancer and Stromal-Cell Interaction in the Pancreatic-cancer Tumor Microenvironment (TME).
    Suetsugu A; Hoffman RM
    Methods Mol Biol; 2021; 2224():99-111. PubMed ID: 33606209
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC.
    Olaoba OT; Ligali FC; Alabi ZO; Akinyemi AO; Ayinde KS
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188483. PubMed ID: 33232723
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression.
    Tolosa EJ; Fernandez-Barrena MG; Iguchi E; McCleary-Wheeler AL; Carr RM; Almada LL; Flores LF; Vera RE; Alfonse GW; Marks DL; Hogenson TL; Vrabel AM; Horn IP; Koenig AN; Safgren SL; Sigafoos AN; Erkan M; Romecin-Duran PA; Sarabia Gonzalez A; Zhou B; Javelaud D; Marsaud V; Graham RP; Mauviel A; Elsawa SF; Fernandez-Zapico ME
    Biochem J; 2020 Sep; 477(17):3131-3145. PubMed ID: 32766732
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tripartite motif containing 14: An oncogene in papillary thyroid carcinoma.
    Sun W; Wang Y; Li D; Wu Y; Ji Q; Sun T
    Biochem Biophys Res Commun; 2020 Jan; 521(2):360-367. PubMed ID: 31668806
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Global, regional and national burden of testicular cancer, 1990-2016: results from the Global Burden of Disease Study 2016.
    Pishgar F; Haj-Mirzaian A; Ebrahimi H; Saeedi Moghaddam S; Mohajer B; Nowroozi MR; Ayati M; Farzadfar F; Fitzmaurice C; Amini E
    BJU Int; 2019 Sep; 124(3):386-394. PubMed ID: 30953597
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Intratumoral Delivery of an Adenoviral Vector Carrying the
    Nakagawa S; Serada S; Kakubari R; Hiramatsu K; Sugase T; Matsuzaki S; Matsuzaki S; Ueda Y; Yoshino K; Ohkawara T; Fujimoto M; Kishimoto T; Kimura T; Naka T
    Mol Cancer Ther; 2018 Sep; 17(9):1941-1950. PubMed ID: 29891489
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Significance of expression of suppressor of cytokine signaling proteins: Suppressor of cytokine signaling-1, suppressor of cytokine signaling-2, and suppressor of cytokine signaling-3 in papillary thyroid cancer.
    Kobawala TP; Trivedi TI; Gajjar KK; Patel GH; Ghosh NR
    J Cancer Res Ther; 2017; 13(2):337-345. PubMed ID: 28643757
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. cancer-Associated Fibroblasts in Pancreatic cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation.
    Xiao Q; Zhou D; Rucki AA; Williams J; Zhou J; Mo G; Murphy A; Fujiwara K; Kleponis J; Salman B; Wolfgang CL; Anders RA; Zheng S; Jaffee EM; Zheng L
    Cancer Res; 2016 Sep; 76(18):5395-404. PubMed ID: 27496707
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Upregulation of miR-572 transcriptionally suppresses socs1 and p21 and contributes to human ovarian cancer progression.
    Zhang X; Liu J; Zang D; Wu S; Liu A; Zhu J; Wu G; Li J; Jiang L
    Oncotarget; 2015 Jun; 6(17):15180-93. PubMed ID: 25893382
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.
    Zhou Y; Zhang X; Klibanski A
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):16-33. PubMed ID: 24035864
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through socs1.
    Huang C; Li H; Wu W; Jiang T; Qiu Z
    Oncol Rep; 2013 Sep; 30(3):1223-30. PubMed ID: 23817566
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Overexpression of pro-inflammatory genes and down-regulation of socs-1 in human PTC and in hypoxic BCPAP cells.
    De Santis E; Di Vito M; Perrone GA; Mari E; Osti M; De Antoni E; Coppola L; Tafani M; Carpi A; Russo MA
    Biomed Pharmacother; 2013 Feb; 67(1):7-16. PubMed ID: 23089475
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Expression of miR-130a in cisplatin resistant cell lines of ovarian cancer].
    Yang LY; Wang HJ; Jia XB; Wang X; Luo J; Zhang XY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):60-4. PubMed ID: 22455133
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancer.
    Zeimet AG; Reimer D; Schwentner L; Fuchs D; Wolf D; Fuith LC; Fiegl H; Doppler W; Concin N; Daxenbichler G; Marth C
    Cancer Immunol Immunother; 2010 Dec; 59(12):1813-23. PubMed ID: 20717669
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells.
    Saydmohammed M; Joseph D; Syed V
    J Cell Biochem; 2010 May; 110(2):447-56. PubMed ID: 20235152
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy.
    Francipane MG; Eterno V; Spina V; Bini M; Scerrino G; Buscemi G; Gulotta G; Todaro M; Dieli F; De Maria R; Stassi G
    Cancer Res; 2009 Aug; 69(15):6141-8. PubMed ID: 19638576
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Methylation profile of circulating plasma DNA in patients with pancreatic cancer.
    Melnikov AA; Scholtens D; Talamonti MS; Bentrem DJ; Levenson VV
    J Surg Oncol; 2009 Feb; 99(2):119-22. PubMed ID: 19065635
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.